US export curbs can limit COVID-19 vaccine production, availability: SII CEO Adar Poonawalla

SII, the world's biggest vaccine maker, has licensed the AstraZeneca/Oxford University product and will soon start bulk-manufacturing the Novavax shot.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news